![Lekhram Changoer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lekhram Changoer
Directeur Technique/Scientifique/R&D chez CANAFARMA HEMP PRODUCTS CORP.
Fortune : 2 M $ au 31/05/2024
Postes actifs de Lekhram Changoer
Sociétés | Poste | Début | Fin |
---|---|---|---|
CANAFARMA HEMP PRODUCTS CORP. | Directeur Technique/Scientifique/R&D | - | - |
INCANNEX HEALTHCARE INC. | Directeur Technique/Scientifique/R&D | 28/06/2022 | - |
Stichting Sanammad | Directeur/Membre du Conseil | 01/01/2009 | - |
Corporate Officer/Principal | 01/01/2009 | - | |
Sanammad Pharmaceuticals BV | Directeur/Membre du Conseil | 01/01/2014 | - |
Corporate Officer/Principal | 01/01/2014 | - |
Historique de carrière de Lekhram Changoer
Anciens postes connus de Lekhram Changoer
Sociétés | Poste | Début | Fin |
---|---|---|---|
AXIM BIOTECHNOLOGIES, INC. | Directeur/Membre du Conseil | 01/05/2014 | 06/05/2020 |
Directeur Technique/Scientifique/R&D | 01/05/2014 | 06/05/2020 | |
APIRX Pharmaceuticals USA LLC
![]() APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Fondateur | - | - |
CanChew Biotechnologies LLC
![]() CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Directeur/Membre du Conseil | 01/01/2012 | - |
Directeur Technique/Scientifique/R&D | 30/07/2013 | - | |
Fondateur | 01/01/2012 | - |
Statistiques
Internationale
Pays-Bas | 4 |
Etats-Unis | 4 |
Canada | 2 |
Opérationnelle
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Sectorielle
Health Technology | 5 |
Miscellaneous | 2 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
AXIM BIOTECHNOLOGIES, INC. | Health Technology |
CANAFARMA HEMP PRODUCTS CORP. | Process Industries |
INCANNEX HEALTHCARE INC. | Health Technology |
Entreprise privées | 4 |
---|---|
CanChew Biotechnologies LLC
![]() CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
Stichting Sanammad | Miscellaneous |
Sanammad Pharmaceuticals BV | |
APIRX Pharmaceuticals USA LLC
![]() APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Bourse
- Insiders
- Lekhram Changoer
- Expérience